tiprankstipranks
Mirum Pharmaceuticals price target raised to $49 from $47 at Leerink
PremiumThe FlyMirum Pharmaceuticals price target raised to $49 from $47 at Leerink
1M ago
Mirum Pharmaceuticals granted Breakthrough Therapy Designation for volixibat
Premium
The Fly
Mirum Pharmaceuticals granted Breakthrough Therapy Designation for volixibat
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Mirum Pharmaceuticals reports Q2 EPS (52c), consensus (47c)
PremiumThe FlyMirum Pharmaceuticals reports Q2 EPS (52c), consensus (47c)
4M ago
Mirum Pharmaceuticals announces label expansion for Livmarli
Premium
The Fly
Mirum Pharmaceuticals announces label expansion for Livmarli
4M ago
Mirum Pharmaceuticals: EU approves LIVMARLI for patients with PFIC
Premium
The Fly
Mirum Pharmaceuticals: EU approves LIVMARLI for patients with PFIC
5M ago
Mirum Pharmaceuticals price target raised to $39 from $34 at Baird
PremiumThe FlyMirum Pharmaceuticals price target raised to $39 from $34 at Baird
5M ago
Mirum Pharmaceuticals price target raised to $39 from $31 at JPMorgan
Premium
The Fly
Mirum Pharmaceuticals price target raised to $39 from $31 at JPMorgan
5M ago
Mirum Pharmaceuticals price target raised to $57 from $53 at Morgan Stanley
Premium
The Fly
Mirum Pharmaceuticals price target raised to $57 from $53 at Morgan Stanley
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100